Cecília Rodrigues

We investigate novel mechanism-based molecular targets to inform drug discovery and biomarker development in inflammation, degenerative and oncogenic diseases. We specifically address cell signaling and the crosstalk with metabolism and interorgan communication, integrating cellular and molecular technologies with multiple preclinical and patient-derived models and samples to facilitate the translation from bench to bedside.